Advanced Search
CASE REPORTS  
CMH 2013 June;19:179-184.
Published online 2013 June 27. doi:http://dx.doi.org/10.3350/cmh.2013.19.2.179
Copyright © 2013 The Korean Association for the Study of the Liver
  |  Abstract   |  PDF Links PDF Links   |   Download Citation
A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver disease
Heon Ju Lee and Myung Jin Oh
Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea
Corresponding Author: Heon Ju Lee ,Tel: +82-53-620-3830, Fax: +82-53-654-8386, Email: hjlee@med.yu.ac.kr
ABSTRACT
Variceal bleeding and hepatorenal syndrome (HRS) are serious and life-threatening complications of advanced liver disease. Terlipressin is widely used to manage both acute variceal bleeding and HRS due to its potency and long duration of action. The most severe (though rare) adverse event is ischemia. The present report describes the case of a patient with gangrene and osteomyelitis secondary to terlipressin therapy. A 71-year-old male with alcoholic liver cirrhosis (Child-Pugh B) and chronic hepatitis C was admitted due to a drowsy mental status. The patient had several experiences of orthopedic surgery. His creatinine level had gradually elevated to 4.02 mg/dL, and his urine output decreased to 500 mL/24 hr. The patient was diagnosed as having grade III hepatic encephalopathy (HE) and type II HRS. Terlipressin and albumin were administered intravenously to treat the HRS over 11 days. Although he recovered from the HE and HRS, the patient developed peripheral gangrene and osteomyelitis in both feet. His right toes were cured with the aid of rescue therapy, but his left three toes had to be amputated. Peripheral gangrene and osteomyelitis secondary to terlipressin therapy occur only rarely, and there is no specific rescue therapy for these conditions. Thus, attention should be paid to the possibility of ischemia of the skin and bone during or after terlipressin therapy.
Keywords: Liver cirrhosis; Hepatorenal syndrome; Terlipressin; Gangrene; Osteomyelitis
Don't forget to sign up for journal e-mail alerts so you can keep up to date with all the articles as they are published.
e-submission
CMH
  
vol: Issue: Page:
  
Author's home
Reviewer's home
Editor's home
The Korean Association for the Study of the Liver
KoMCI
PubMed
PubMed Central
Sypapse
KoreaMed
CrossCheck
Crossref
Register for e-submission
Register here to access the e-submission system of CMH for authors and reviewers.
Manuscript Submission
To submit a manuscript, please visit the CMH e-submission management system at http://submit.e-cmh.org, read the Instructions for Authors, and log into the CMH e-submission system. For assistance with manuscript submission, please contact: kasl@kams.or.kr.
Free archive
Anyone may access any past or current articles without logging in.
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero{MapoTrapalace , Dowha-dong}, Mapo-gu, Seoul, 121-784, Korea
TEL : +82-2-703-0051    FAX : +82-2-703-0071   E-mail : kasl@kams.or.kr
Copyright © By The Korean Association for the Study of the Liver. All right reserved.